{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:11:33Z","timestamp":1794852693857,"version":"4.9.1"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study analyzed metabolic indicators and height gain in short-statured children within the first year of recombinant human growth hormone (rhGH) therapy, identifying predictive factors for treatment efficacy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective analysis of 72 children with short stature (growth hormone deficiency or idiopathic short stature) receiving rhGH therapy (January 2022 to January 2024) was performed. Data included height, weight, age, skeletal age (SA), and laboratory results (IGF1, fasting glucose, insulin, C-peptide, thyroid function, lipids). Analyses focused on height standard deviation score (HSDS), HSDS for SA, and factors associated with 12-month changes in HSDS for SA (\u25b3HSDS for SA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The mean initial rhGH dose was 0.053 \u00b1 0.010mg\/kg\/day, with a mean starting age of 8.36 \u00b1 2.24 years. Significant increases in HSDS and HSDS for SA were observed after 12 months. \u25b3HSDS for SA negatively correlated with baseline homeostasis model assessment of insulin resistance (HOMA-IR) and fasting insulin, and positively correlated with baseline free triiodothyronine (FT3). Children with \u25b3HSDS for SA&amp;gt;0.5 had lower baseline insulin and HOMA-IR, and higher FT3, high-density lipoprotein cholesterol (HDL), and hemoglobin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Insulin resistance, hyperinsulinemia, FT3, and HDL determine rhGH efficacy in short-statured children. Metabolic profiling optimizes rhGH therapy, and targeting insulin resistance may improve growth outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2025.1691509","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T06:24:43Z","timestamp":1762410283000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Metabolic factors influencing the efficacy of recombinant human growth hormone therapy in children with short stature"],"prefix":"10.3389","volume":"16","author":[{"given":"Xueyu","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhai","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuanhong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangli","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.23736\/S0026-4946.20.05821-1","article-title":"Dilemmas of growth hormone treatment for GH deficiency and idiopathic short stature: defining, distinguishing, and deciding","volume":"72","author":"Halas","year":"2020","journal-title":"Minerva Pediatr"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac517","article-title":"Safety and efficacy of pediatric growth hormone therapy: results from the full KIGS Cohort","volume":"107","author":"Maghnie","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ghir.2018.09.003","article-title":"Efficacy and safety of recombinant human growth hormone in treating Chinese children with idiopathic short stature","author":"Ying","year":"2018","journal-title":"Growth Horm IGF Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2147\/tcrm.s3635648","article-title":"A real-world study of recombinant human growth hormone in the treatment of idiopathic short stature and growth hormone deficiency","volume":"18","author":"Gou","year":"2022","journal-title":"Ther Clin Risk Manage"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1186\/1687-9856-2011-6","article-title":"Identification of factors associated with good response to growth hormone therapy in children with short stature: results from the ANSWER Program\u00ae","volume":"2011","author":"Lee","year":"2011","journal-title":"Int J Pediatr Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-024-03984-0","article-title":"BMI z-score as a prognostic factor for height velocity in children treated with recombinant human growth hormone due to idiopathic growth hormone deficiency","volume":"86","author":"Budzulak","year":"2024","journal-title":"Endocrine"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/jendso\/bvad026","article-title":"Factors associated with response to growth hormone in pediatric growth disorders: Results of a 5-year Registry Analysis","volume":"7","author":"Ross","year":"2023","journal-title":"J Endocr Soc"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-017-0786-8","article-title":"Recombinant growth hormone therapy for prepubertal children with idiopathic short stature in Korea: a phase III randomized trial","volume":"41","author":"Kim","year":"2017","journal-title":"J Endocrinol Invest"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1530\/EC-17-0277","article-title":"Pre-treatment growth and IGF-I deficiency as main predictors of response to growth hormone therapy in neural models","volume":"7","author":"Smyczy\u0144ska","year":"2018","journal-title":"Endocrine Connections"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4183\/aeb.2016.443","article-title":"Evaluation of first year response to treatment in cases with growth hormone deficiency","volume":"12","author":"K\u00f6r","year":"2016","journal-title":"Acta Endocrinol (Buc)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1210\/er.2008-0027","article-title":"Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects","volume":"30","author":"M\u00f8ller","year":"2009","journal-title":"Endocr Rev"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-20-0616","article-title":"Suppression of hyperinsulinemia restores growth hormone secretion and metabolism in obese mice","volume":"250","author":"Huang","year":"2021","journal-title":"J Endocrinol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e96","DOI":"10.1210\/clinem\/dgad491","article-title":"Insulin signaling through the insulin receptor increases linear growth through effects on bone and the GH-IGF-1 Axis","volume":"109","author":"Okawa","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.19538\/j.ek2023110601","article-title":"Chinese expert consensus on the diagnosis and treatment of children with idiopathic short stature","volume":"38","author":"Chen","year":"2023","journal-title":"Chin J Pract Pediatr"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0578-1310.2009.07.003","article-title":"Height and weight standardized growth charts for Chinese children and adolescents aged 0 to 18 years","volume":"47","author":"Li","year":"2009","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.13294\/j.aps.2017.0062","article-title":"Influence of insulin on growth hormone secretion, level and growth hormone signalling","volume":"69","author":"Qiu","year":"2017","journal-title":"Acta Physiol Sin"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-017-1408-0","article-title":"Glucose homeostasis in GHD children during long-term replacement therapy: a case-control study","volume":"59","author":"Capalbo","year":"2018","journal-title":"Endocrine"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-014-0184-4","article-title":"Reduction in insulin sensitivity and inadequate \u03b2-cell capacity to counteract the increase in insulin resistance in children with idiopathic growth hormone deficiency during 12 months of growth hormone treatment","volume":"37","author":"Ciresi","year":"2014","journal-title":"J Endocrinol Invest"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2020.04.005","article-title":"Insulin and growth hormone balance: Implications for obesity","volume":"31","author":"Huang","year":"2020","journal-title":"Trends Endocrinol Metab"},{"key":"B20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13633-016-0036-4","article-title":"The influence of a long-term growth hormone treatment on lipid and glucose metabolism: a randomized trial in short Japanese children born small for gestational age","volume":"2016","author":"Horikawa","year":"2016","journal-title":"Int J Pediatr Endocrinol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa674","article-title":"Lipid management in patients with endocrine disorders: An endocrine society clinical practice guideline","volume":"105","author":"Newman","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22157797","article-title":"Hyperinsulinemia and its pivotal role in aging, obesity, type 2 diabetes, cardiovascular disease and cancer","volume":"22","author":"Janssen","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4408","article-title":"Genes with specificity for expression in the round cell layer of the growth plate are enriched in genomewide association study (GWAS) of human height","volume":"36","author":"Renthal","year":"2021","journal-title":"J Bone Miner Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1053\/j.ajkd.2022.09.019","article-title":"Longitudinal relationship between anemia and statural growth impairment in children and adolescents with nonglomerular CKD: Findings from the Chronic Kidney Disease in Children (CKiD) Study","volume":"81","author":"Akchurin","year":"2023","journal-title":"Am J Kidney Dis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12916-020-01879-1","article-title":"Association of sickle cell disease with anthropometric indices among under-five children: evidence from 2018 Nigeria Demographic and Health Survey","volume":"19","author":"Islam","year":"2021","journal-title":"BMC Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/nutrit\/nuaf019","article-title":"Comparison of effects of iron and multiple micronutrient supplementation on hematological and growth indicators among older children, adolescents and young adults in low- and middle-income countries: A systematic review and meta-analysis of randomized controlled trials","volume":"83","author":"Zhao","year":"2025","journal-title":"Nutr Rev"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1691509\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T11:54:29Z","timestamp":1762430069000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1691509\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":26,"alternative-id":["10.3389\/fendo.2025.1691509"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1691509","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]},"article-number":"1691509"}}